AI assistant
CONMED Corp — Director's Dealing 2016
Apr 4, 2016
31971_dirs_2016-04-04_6468466c-e901-460b-90a7-322f2b29e038.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-03-31
Reporting Person: Snyder Mark D (EVP Mfg. Ops & Business System)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-31 | Common Stock | M | 1200 | — | Acquired | 15462 | Direct |
| 2016-03-31 | Common Stock | F | 329 | $41.94 | Disposed | 15133 | Direct |
| 2016-03-31 | Common Stock | M | 800 | — | Acquired | 15933 | Direct |
| 2016-03-31 | Common Stock | F | 219 | $41.94 | Disposed | 15714 | Direct |
| 2016-03-31 | Common Stock | M | 1600 | — | Acquired | 17314 | Direct |
| 2016-03-31 | Common Stock | F | 438 | $41.94 | Disposed | 16876 | Direct |
| 2016-03-31 | Common Stock | M | 2400 | — | Acquired | 19276 | Direct |
| 2016-03-31 | Common Stock | F | 657 | $41.94 | Disposed | 18619 | Direct |
| 2016-03-31 | Common Stock | M | 2080 | — | Acquired | 20699 | Direct |
| 2016-03-31 | Common Stock | F | 569 | $41.94 | Disposed | 20130 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2020-06-01 | Common Stock (1200) | Direct |
| 2016-03-31 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2016-03-31 | Rsus (restricted Stock Units) | $0 | M | 1600 | Disposed | 2022-06-01 | Common Stock (1600) | Direct |
| 2016-03-31 | Rsus (restricted Stock Units) | $0 | M | 2400 | Disposed | 2023-06-01 | Common Stock (2400) | Direct |
| 2016-03-31 | Rsus (restricted Stock Units) | $0 | M | 2080 | Disposed | 2024-06-01 | Common Stock (2080) | Direct |
| 2016-03-31 | Rsus (restricted Stock Units) | $0 | D | 900 | Disposed | 2025-02-27 | Common Stock (900) | Direct |
| 2016-03-31 | Sars (Stock Appreciation Rights) | $44.90 | D | 5200 | Disposed | 2024-06-01 | Common Stock (5200) | Direct |
| 2016-03-31 | Sars (Stock Appreciation Rights) | $51.30 | D | 16480 | Disposed | 2025-02-27 | Common Stock (16480) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.